Diagnostics; making a difference

Press Releases

Current Articles | Categories | Search | Syndication

12 June 2013  Sharron Pillay
Proteome Sciences announces deal with Thermo Fisher Scientific to develop cancer pathway profiling assays
By Sharron Pillay @ 09:17 :: 30 Views



Proteome Sciences announcing the company’s largest contract to date, a technology agreement with Thermo Fisher Scientific, valued at $2.1million, to develop advanced methods to profile changes in key cancer pathways. 

 
Read More
06 June 2013  Sharron Pillay
Siemens and Iron Man raise profile of diabetes prevalence
By Sharron Pillay @ 11:26 :: 26 Views



Siemens Healthcare Diagnostics is raising awareness of the prevalence of diabetes among adolescents to healthcare professionals with the help of Marvel Super Hero, Iron Man. 
Read More
30 May 2013  Sharron Pillay
Roche award winning IT solution launched in the UK
By Sharron Pillay @ 15:54 :: 62 Views



Improving efficiency and productivity of the professional laboratory just got easier: Roche continues to demonstrate its lead in total automated workflow solutions with the launch of cobas IT middleware
Read More
30 May 2013  Sharron Pillay
Proteome Sciences - Preliminary results announcement
By Sharron Pillay @ 10:39 :: 53 Views



Proteome Sciences announcing the company’s preliminary results for the year ended 31st December 2012 including an outlook for the current year.
Read More
29 May 2013  Sharron Pillay
UK Trade and Investment joins hands with Randox Laboratories Ltd. UK to organise healthcare seminars in Pakistan
By Sharron Pillay @ 12:04 :: 64 Views



Randox Laboratories Ltd. UK in association with UK Trade and Investment Pakistan organised seminars in Karachi, Lahore and Islamabad from 22nd to 24th May, on “Improving Healthcare and Laboratory performance in Pakistan.”
Read More
30 April 2013  Sharron Pillay
Multiplate helps to improve outcomes for patients on anti-platelet therapy: Roche further strengthens its vision for personalised healthcare with Multiplate analyser
By Sharron Pillay @ 12:03 :: 124 Views


Media Release  

Burgess Hill, UK, 30 April 2013
Read More
30 April 2013  Sharron Pillay
Randox licenses sPLA2 CVD risk test from Aterovax
By Sharron Pillay @ 11:21 :: 136 Views



Randox Laboratories Ltd., a privately owned UK diagnostic company with an extensive portfolio of diagnostic markers for Cardiovascular disease (CVD) and Aterovax SA, a privately owned French diagnostic company focused on the development and commercialisation of novel cardiovascular diagnostics have announced a strategic partnership to commercialise Aterovax’s patented biomarker secreted Phospholipase A2 (sPLA2) for the assessment of cardiovascular risk.
Read More
22 April 2013  Sharron Pillay
Randox Toxicology launches ELISA for the detection of new generation Synthetic Cannabinoids; UR-144 and XLR-11
By Sharron Pillay @ 15:03 :: 131 Views



Randox Toxicology has launched an ELISA for the detection of new generation Synthetic Cannabinoids; UR-144, XLR-11, and additional compounds which are commonly found in ‘Spice’ and ‘K2’ blends.
Read More
11 April 2013  Sharron Pillay
Oxford Immunotec wins 2013 Red Herring Top 100 Award
By Sharron Pillay @ 08:48 :: 153 Views


Oxford, UK and Marlborough, MA; 11 April 2013
Read More
10 April 2013  Sharron Pillay
Randox Toxicology launches Mitragynine ELISA for the detection of designer drug Kratom
By Sharron Pillay @ 11:27 :: 169 Views



Crumlin, UK, 10th April 2013

Kratom is a designer drug which originates from Mitragyna speciosa; an uncontrolled plant found in South East Asia.





Read More
Paging - Page: 1 of 18
Previous Page | Next Page
The British In Vitro Diagnostics Association (BIVDA)
About Us News General Information Blog Jobs Links Contact Us
Site Map Terms of Use Privacy Statement Code of Conduct / Business Practice

 

 

©2012 BIVDA BIVDA Ltd is registered in England, with Company Number 2687137
Registered Office is 1 Queen Anne's Gate, London SW1H 9BT VAT Number 563105858